ANI MINASYAN: Open Payments
NPI 1467225169 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 47 payments from 18 companies in 2025. Trend: 2023 $83 · 2024 $766 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $245 |
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| Edwards Lifesciences Corporation | 1 | $157 |
| Abbott Laboratories | 1 | $156 |
| Regeneron Healthcare Solutions, Inc. | 3 | $116 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Kestra Medical Technology Services, Inc. | 3 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
Products named: JARDIANCE, SAPIEN 3 Ultra RESILIA, TRICLIP, LEQVIO, EVKEEZA, Assure WCD, Kerendia, FARXIGA.
Industry payments across CA — which companies pay providers there.
